BioSpace News Archive

Business

Kaleido Biosciences Announces Appointment of Joshua Brumm as Chief Financial Officer

Kaleido Biosciences, a clinical-stage biotechnology company developing novel chemistries to unlock the power of the human microbiome, today announced the appointment of Joshua Brumm as chief financial officer.

April 23, 2018
·
3 min read
FDA

Pfizer Granted FDA Breakthrough Therapy Designation for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Children Ages 1 to 9 Years

This is the first Breakthrough Therapy designation for a MenB vaccine to help protect children as young as 1 year of age.

April 23, 2018
·
9 min read
FDA

Amerigen and Dipharma Announce U.S. FDA Approval for Generic Miglustat 100 mg Capsules

The first generic version of Miglustat is now approved in the U.S.

April 23, 2018
·
3 min read
BioMidwest

Prime Therapeutics Finds Poor Adherence to High-Cost Multiple Sclerosis Therapy

Disease-modifying drugs produce significantly fewer relapses, cost-effectiveness in question

April 23, 2018
·
4 min read
Pharm Country

Regeneron Announces Upcoming Investor Conference Presentations

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations

April 23, 2018
·
1 min read
Pharm Country

Elusys Receives Second Delivery Order From U.S. Government for ANTHIM®, its Treatment for Inhalation Anthrax

Elusys receives $19.7 million for delivery of ANTHIM under first Delivery Order

April 23, 2018
·
7 min read
Lone Star Bio

DecisionDx-Melanoma Test Independently Improved Identification of High-Risk Patients Compared to AJCC Staging in Stage I-II Cutaneous Melanoma

Posters presented at the Real World Dermatology for Physician Assistants and Nurse Practitioners conference also include data demonstrating test’s clinical utility

April 23, 2018
·
5 min read
BioMidwest

Thermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics Capabilities

Project will increase capacity to meet growing customer demand

April 23, 2018
·
3 min read